Anybody concerned about Chromadex's effect on Exenical?
Is anybody concerned about Chromadex’s potential affect on Roche’s exenical? I know the solutions are different, but I’m thinking with a more health conscious consumer, some of Roche’s business could be switching to Chromadex over the longer term. I think a lot of the switching will be dependent upon the results of Chromadex’s human trials set to be reported in the next couple of weeks.
I’m not real concerned about Chromadex’s effect on Exenical, although I think there will be some marginal positive impact for Chromadex. I’m wondering if Chromadex would be a good takeover target for Roche? Does anyone think Roche would be interested in any synergies the two could create together? Maybe there are no synergies?